Registry of Lobbyists
| Organization: | Novo Nordisk Canada Inc. |
| Associated registration: | 954988-360616-15 |
| Communication date: | 2023-09-19 |
| Posted date: | 2023-10-16 |
| Designated Public Office Holders who participated in the communication: |
Danna Campbell,
Director, Partnerships & Strategies
Health Promotion and Chronic Disease Prevention Branch, Health Canada (HC) Michael Collins, A/Vice-President Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada (PHAC) David Luchuk, A/Director Health Promotion and Chronic Disease Prevention Branch, Centre for Chronic Disease Prevention and Health Equity, Policy and Engagement Division, Public Health Agency of Canada (PHAC) |
| Subject Matter of the communication: | Health |
| Responsible Officer who filed this communication report: | Vince Lamanna |
| As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed. | |